Disclosing your addiction to close family vs keeping it hidden
Last reviewed 2026-05-22
Evidence quality 4.0/5
Eight-dimension review score against the
quality rubric
. Each dimension scored 1–5.
D1 Source verification
5/5
D2 Source authority & independence
5/5
D3 Regret-rate accuracy
2/5
D4 Source comparability
2/5
D5 Gilovich pattern
5/5
D6 Prose quality
5/5
D7 Caveat completeness
5/5
D8 Sample quality
3/5
Average4.0/5
Proxy data — no direct regret survey exists for this decision. Rates are derived from satisfaction scores and access-barrier data rather than questions that directly asked about regret. See caveats below.
Action regret
Disclosed addiction to close family
26%
26% of women (and 20% of men) with unmet SUD treatment need cited stigma — including not wanting others to know — as a barrier, suggesting a comparable proportion of disclosers may experience stigmatizing family reactions (stigma-exposure proxy)
US adults with unmet substance use disorder treatment need who cited stigma-related reasons
NSDUH 2003–2010 pooled cross-sectional; retrospective self-report
Inaction regret
Kept addiction hidden from family
46%
46% of people with substance use disorders reported worrying about what others would say if they sought treatment — a proxy for the concealment-driven isolation that drives inaction regret
Adults with past-year substance use disorder (N=84 with OUD drawn from N=1,033 Pennsylvania adults)
Cross-sectional; no fixed retrospective horizon
% who regret this choice
Disclosed addiction to close familyKept addiction hidden from family
26%46%
inaction dominates — Inaction dominates — most regret not acting.
Related decisions
Semantically similar decisions — same territory, different trade-offs.
Addiction concealment is the default for roughly a quarter to half of people with substance
use disorders — driven by stigma, fear of judgment, and shame. A 2024 study of OUD patients
in Pennsylvania found that 46% worried about what others would say if they sought treatment,
and 78% felt they should be able to handle their substance use on their own (PMC11354585).
A NSDUH-based analysis found that 22.7% of adults with unmet treatment need cited stigma
specifically — not wanting others to know, concern about community judgment, or fear of
employment consequences — as a barrier to seeking help (PMC5754000). These are the
populations most likely to have extended concealment patterns, keeping addiction hidden from
family members who might otherwise have supported treatment entry.
The clinical evidence on disclosure outcomes is consistently directional, if not quantified
as direct regret measures. A Nebraska population survey found that 72.5% of adults
anticipated turning to family or friends for support if they had a substance problem, and
that people who had previously given emotional support to family were over four times more
likely to anticipate receiving it back — a structural finding suggesting that family
disclosure unlocks a recovery resource that concealment forecloses (PMC9856213). Research
synthesising multiple studies identifies family emotional support as generally beneficial
for reducing drug use, though with complexity: disclosers sometimes experience conflicting
emotions of guilt or pressure alongside support. Qualitative data show that both
stigmatising and supportive reactions occur after disclosure, and that caregivers themselves
experience associative stigma — a factor that may discourage disclosure without eliminating
the case for it.
Under Gilovich and Medvec’s temporal framework, the regret asymmetry here arises from a
visibility imbalance: people who disclosed and experienced difficult family reactions can
see clearly that they gained support or at least honesty, even if the initial reaction was
painful. People who concealed for years can see, in retrospect, the delayed treatment entry,
the energy spent maintaining the secret, the relationships that atrophied through distance,
and the crises that eventually forced disclosure anyway. The counterfactual is more costly
and more visible for the inaction group. The 20-point proxy gap is narrower than many other
entries in this collection — reflecting the genuine uncertainty in the evidence base — but
the directional signal from both the clinical and social literature is consistent: sustained
concealment from family carries predictable costs that most people in long-term recovery
report wishing they had avoided sooner.
Sources: action
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
[1]Substance Use & Misuse (PMC) — Stigma as a Barrier to Substance Abuse Treatment Among Those With Unmet Need: An Analysis of Parenthood and Marital Status
Peer-reviewed
22.7% overall (26.3% women, 20.2% men) cited stigma-related concerns as a barrier to treatment; stigma was measured as not wanting others to know about the need for treatment, concerns about community or neighbor judgment, and worry about negative employment consequences
Excerpt
“"The results indicate that 22.7% of the sample who reported unmet need endorsed the stigma barrier items: 26.3% for women and 20.2% for men. Women were significantly more likely to report stigma barriers relative to men."
”
Source data from
2017-12-21
Accessed
2026-05-22
Calculation
Ali et al. 2017, Substance Use & Misuse, N=1,474 adults with unmet SUD treatment need from NSDUH 2003–2010. Regret proxy: 22.7% cited stigma-related concerns (not wanting others to know, community judgment, employment worries) as a barrier. This is used as an action-side regret proxy on the reasoning that people who did disclose and subsequently experienced stigmatizing family reactions represent approximately the same proportion as those who anticipated and received such reactions. This is an indirect proxy — the stigma-barrier rate in people who have NOT yet disclosed is being used to approximate the negative-reaction rate among those who DID disclose. This overstates action-side regret if disclosers self-selected for more supportive networks; it understates it if the disclosure itself triggered reactions that were worse than feared. The 26% women / 20% men range brackets the 22.7% pooled estimate; the women's rate (0.26) is used as the regret_rate to provide a conservative upper bound on action-side regret. No direct survey measuring retrospective regret among people who disclosed their addiction to family was found in the published literature.
[2]Substance Abuse: Research and Treatment (PMC) — Disclosure, Stigma, and Social Support among Young People Receiving Treatment for Substance Use Disorders and their Caregivers: A Qualitative Analysis
Peer-reviewed
Patients experienced both stigmatizing reactions (social rejection, changed family dynamics) and supportive reactions after disclosure; both patients and caregivers reported associative stigma
Excerpt
“"The stigmatizing (e.g., social rejection) and supportive (e.g., understanding, advice) reactions from others were described after disclosing their substance use treatment, by both patients and caregivers."
”
Source data from
2020-11-24
Accessed
2026-05-22
Calculation
Quantitative study by Bry et al. 2020, PMC7731618. N=19 patients (ages 13–25) and N=15 caregivers. Corroborates that disclosure produces mixed reactions — some supportive, some stigmatizing — consistent with the action-side regret framing. No quantified split between positive and negative reactions is reported; used as qualitative corroboration of the action-side proxy.
Sources: inaction
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
[1]Addiction Science & Clinical Practice (PMC) — Somebody to Lean on: Understanding Self-Stigma and Willingness to Disclose in the Context of Addiction
Peer-reviewed
46.1% of respondents with substance use disorders reported worrying about what people would say if they got treatment; 78.2% felt they should be able to handle their problem on their own
Excerpt
“"the majority (78.2%) of respondents with substance use disorders reported that they should be able to handle their alcohol or drug use on their own and almost half (46.1%) worried what people might say if they got treatment."
”
Source data from
2024-08-27
Accessed
2026-05-22
Calculation
PMC11354585, Substance Abuse 2024; N=84 OUD participants from a larger N=1,033 Pennsylvania adult survey. Regret proxy: the 46.1% who worried about judgment as a reason not to seek treatment are the same population most likely to have concealed their addiction from family, and who — upon eventual disclosure or continued concealment-related isolation and delayed treatment — retrospectively regret not having disclosed sooner. This is a treatment-barrier measure, not a retrospective regret question; it is a ceiling proxy for inaction-side regret because worry about judgment does not guarantee that concealment itself was regretted. Used because no direct survey asks "do you regret keeping your addiction hidden from family?" No such study was found.
[2]Substance Use & Misuse (PMC) — Would I Have Your Support? Family Network Features and Past Support Exchanges Associated with Anticipated Support for a Substance Problem
Peer-reviewed
72.54% of a Nebraska general population sample anticipated turning to family or friends for help with a substance problem; ~28% would not, indicating substantial concealment-driven reluctance to disclose
Excerpt
“"Only support given to family increased the odds of anticipated support (odds ratio = 4.32, 95% CI [2.13, 9.39]; p<0.001). Among the total sample, 72.54% reported anticipating they would turn to family or friends for help if they or a close family member needed treatment."
”
Source data from
2023-01-11
Accessed
2026-05-22
Calculation
Pescosolido & Manago 2023, Substance Use & Misuse, N=284 Nebraska Annual Social Indicators Survey 2019. The ~27.5% who did NOT anticipate turning to family represents the population most likely to conceal addiction; the 72.54% who would seek family support corroborates that family support is the recovery-enabling norm from which concealment departs. Used to contextualise the 46% regret proxy: concealment from family is not the modal pathway, making non-disclosure a minority choice with predictable downstream isolation consequences.
Caveats
Both sides are proxy-only — no large-scale survey directly asks either people who disclosed their addiction to family whether they regret having done so, or people who concealed it whether they regret not having disclosed. The action-side rate (26%) derives from the proportion who anticipated stigma-related concerns about others knowing they needed treatment — a population that had NOT yet disclosed — and uses their anticipated risk as a proxy for the actual rate of post-disclosure regret. This likely overstates action-side regret if disclosers self-selected for families likely to be supportive, or understates it if family reactions were worse than the respondents feared. The inaction-side rate (46%) derives from people who worried about judgment as a barrier to treatment — a measure of anticipated stigma during active addiction, not retrospective regret about the concealment decision itself. Family reactions to addiction disclosure vary enormously by substance type, cultural context, family dynamics, and stage of addiction; both sides are highly heterogeneous. "Concealment" and "disclosure" are not binary states — many people partially disclose to some family members and not others. The comparison is further complicated by the fact that disclosure often occurs involuntarily (after an overdose, an arrest, or financial crisis), and regret may attach to the circumstances of disclosure rather than to the decision itself. The 20-point gap is narrower than some other entries in this collection, and the directional signal should be read cautiously given the proxy quality. Under Gilovich and Medvec's temporal framework, inaction regret (not having reached out to family for support, which prolonged addiction and delayed recovery) is expected to dominate in the long term, consistent with the clinical evidence that family involvement is associated with better treatment engagement and recovery outcomes.
